Loading...

Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches

SIMPLE SUMMARY: Non-small cell lung cancer is the most common type of lung cancer. Anaplastic Lymphoma Kinase (ALK) rearrangements have been found in 5–6% of non-small cell lung cancers. While ALK rearranged non-small cell lung cancer is exquisitely sensitive to ALK directed targeted therapies, it i...

Full description

Saved in:
Bibliographic Details
Published in:Cancers (Basel)
Main Authors: Sankar, Kamya, Nagrath, Sunitha, Ramnath, Nithya
Format: Artigo
Language:Inglês
Published: MDPI 2021
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8004790/
https://ncbi.nlm.nih.gov/pubmed/33806977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061476
Tags: Add Tag
No Tags, Be the first to tag this record!